Company intelligence / Profile preview

Proscia

Philadelphia, Pennsylvania, United Statesproscia.com ↗

Ownership: Private
Development stage: Commercial

Overview

Proscia’s Concentriq platform powers digital transformation in pathology for both clinical diagnostics and life sciences R&D. It supports routine operations as well as advanced applications like biomarker discovery and clinical trial optimization. The company has rapidly grown its user base among top pharmaceutical companies and diagnostic labs. Its real-world data solutions are being used to accelerate precision medicine pipelines. Clinical results per se do not apply since it does not develop therapeutics.

Therapeutic areas: OncologyOther
Modalities: Digital pathology images (whole slide imaging)Real-world data integrationAI-driven analytics and biomarker discovery tools
Industry: Pathology

Partnerships

Agilent TechnologiesSiemens HealthineersPathGroup16 of the top 20 global pharma companies

Beyond the preview

Go deeper on Proscia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proscia.

Explore the full profile